Drug
ropeginterferon alfa-2b
Marketed as BESREMI.
Generic name
ropeginterferon alfa-2b
Brand names
BESREMI
First FDA approval
2021-11-12
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761166 | BESREMI | 2021-11-12 | PHARMAESSENTIA CORP |
Manufacturers
PHARMAESSENTIA CORP
Frequently asked questions
When was ropeginterferon alfa-2b FDA approved?
Earliest FDA approval on record: 2021-11-12.
What brand names are sold as ropeginterferon alfa-2b?
BESREMI.
Sources
Appeal a ropeginterferon alfa-2b denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com